(18.97.14.87)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 9
First page : ( 4299) Last page : ( 4304)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00739.X

Validation of Simple Isocratic RP-UPLC Method for Glecaprevir and Pibrentasvir determination and its Application in the Study of Stress Degradation

Raju Sri Datla V.V. S. S. N.1,*, Manikandan A.1, Rao S. Venkat2

1Department of Chemistry, Bharath Institute of Higher Education and Research, Selaiyur, Chennai-600073, Tamilanadu, India

2SMS Pharmaceuticals Ltd, R & D centre (A DSIR approved), Gagillapur, Telangana-500047, India

*Corresponding Author E-mail: dvsraju70@gmail.com

Online published on 24 December, 2019.

Abstract

A simple, Accurate, precise method was developed for the simultaneous estimation of the Glecaprevir and Pibrentasvir in tablet dosage form. Chromatogram was run through CHSC18 100 x 4.6 mm, 3μ. Mobile phase containing Buffer 0.01N NaH2PO4.H2O (4.5pH): Acetonitrile taken in the ratio 50:50v/v was pumped through column at a flow rate of 0.3 ml/min. Temperature was maintained at 30°C. Optimized wavelength selected was 260 nm. Retention time of Glecaprevir and Pibrentasvir were found to be 0.677 min and 0.965 min. %Recovery was obtained as 99.84% and 100.07% for Glecaprevir and Pibrentasvir individually. LOD, LOQ values obtained from regression equations of Glecaprevir and Pibrentasvir were 0.61, 1.86 and 0.27, 0.73 respectively. Regression equation of Glecaprevir is y = 3763.x + 3938, and y = 4975.x + 4107 of Pibrentasvir.

Top

Keywords

Simultaneous estimation, Glecaprevir, Pibrentasvir, RP-UPLC, LOD and LOQ.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
836,529,155 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.